Anti-HCV treatment with ombitasvir/paritaprevir/ritonavir ± dasabuvir is associated with increased bile acid levels and pruritus
Crossref DOI link: https://doi.org/10.1007/s00508-017-1268-x
Published Online: 2017-10-04
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stauber, Rudolf E.
Fauler, Günter
Rainer, Florian
Leber, Bettina
Posch, Andreas
Streit, Andrea
Spindelboeck, Walter
Stadlbauer, Vanessa
Kessler, Harald H.
Mangge, Harald
License valid from 2017-10-04